Report Categories
View AllRecent Articles
View All
Eli Lilly and Company LLY Announces 23B Planned Acquisition of Ajax Therapeutics to Bolster Hematological Oncology Pipeline
Palo Alto Networks PANW AIPowered Cybersecurity Leadership Presents a Compelling Entry Point Below 190
Andretti POLE Stock Research
IVDA Iveda Solutions beats Q2 2024 EPS expectations by 412 percent but stock slips 067 percent in todays trading
H2O America SPGI Q1 2026 Earnings Align With Guidance Robust Capital Pipeline Supports LongTerm Growth
Illumina Inc ILMN Posts Q1 2026 Earnings Beat Raises FullYear Guidance on Robust NovaSeq X Demand
PYXS Pyxis Oncology Q4 2025 narrower than expected per share loss sparks double digit share price jump today